Report Categories
View AllRecent Articles
View All
Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval
Is PepGen PEPG stock gaining momentum PepGen Delivers 29 EPS Beat Narrower Than Expected Loss
DXC DXC Tech delivers 15 percent Q1 2026 EPS beat but shares slide 328 percent in todays trading
How Horizon HQWWW management quality drives results Investor Concern 20260505